THE POWER OF COMBINATION

At Zucero, we believe that the future of immunotherapy development is positioned in combination therapies, where immunotherapy agents (such as checkpoint inhibitors) are tested in rational combinations with other immunotherapies or targeted therapies to drive a stronger response against cancer.

By combining immunotherapies, or pairing them with other types of cancer treatment such as chemotherapy or radiation, we believe that combination immunotherapy promises to deliver long-term survival benefits that are currently unachievable with current approaches.